Fingolimod Immune Effects Beyond Its Sequestration Ability
Sign Up to like & getrecommendations! Published in 2019 at "Neurology and Therapy"
DOI: 10.1007/s40120-019-00162-7
Abstract: Fingolimod is the first orally administered drug approved for the treatment of relapsing–remitting multiple sclerosis (MS). This drug, modulating sphingosine receptors, regulates the trafficking of lymphocytes between primary and secondary lymphoid organs, trapping naïve T… read more here.
Keywords: beyond sequestration; fingolimod immune; memory cells; fingolimod ... See more keywords